SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Curaxis Pharmaceutical Corp – IPO: ‘S-1/A’ on 10/13/05 – EX-23.1

On:  Thursday, 10/13/05, at 4:17pm ET   ·   Accession #:  1193125-5-200972   ·   File #:  333-128193

Previous ‘S-1’:  ‘S-1’ on 9/9/05   ·   Next:  ‘S-1/A’ on 10/28/05   ·   Latest:  ‘S-1/A’ on 12/8/05

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/13/05  Curaxis Pharmaceutical Corp       S-1/A                  9:1.9M                                   RR Donnelley/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Amendment No. 1 to Form S-1                         HTML   1.21M 
 2: EX-3.1      Amended and Restated Certificate of Incorporation   HTML     68K 
 3: EX-3.4      Amended and Restated By-Laws                        HTML     95K 
 7: EX-10.14    Non-Employee Director Compensation Summary          HTML      9K 
 8: EX-10.15    Executive Officer Compensation Summary              HTML     10K 
 4: EX-10.3     2005 Stock Incentive Plan                           HTML     54K 
 5: EX-10.4     Form of Incentive Stock Option Agreement            HTML     28K 
 6: EX-10.5     Form of Nonstatutory Stock Option Agreement         HTML     29K 
 9: EX-23.1     Consent of Pricewaterhousecoopers LLP               HTML      6K 


EX-23.1   —   Consent of Pricewaterhousecoopers LLP


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  CONSENT OF PRICEWATERHOUSECOOPERS LLP  

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form S-1 of our report dated May 4, 2005, except for Note 11, as to which the date is July 15, 2005, relating to the financial statements of Voyager Pharmaceutical Corporation, which appears in such Registration Statement. We also consent to the references to us under the headings “Experts” and “Selected Financial Data” in such Registration Statement.

 

/s/ PricewaterhouseCoopers LLP

 

Raleigh, North Carolina

October 12, 2005


Dates Referenced Herein

This ‘S-1/A’ Filing    Date    Other Filings
Filed on:10/13/05None on these Dates
10/12/05
7/15/05
5/4/05
 List all Filings 
Top
Filing Submission 0001193125-05-200972   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 11:30:38.1am ET